Solventum (SOLV) Total Non-Current Liabilities (2023 - 2026)
Solventum's (SOLV) quarterly Total Non-Current Liabilities came in at $8.6 billion in Q1 2026, down 21.26% YoY from $11.0 billion in Q1 2025, and down 0.55% on a QoQ basis from $8.7 billion in Q4 2025.
Solventum (SOLV) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends
Solventum (SOLV) has 4 years of Total Non-Current Liabilities data on file, last reported at $8.6 billion in Q1 2026.
- Quarterly Total Non-Current Liabilities fell 21.26% year-over-year to $8.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 billion (down 21.26% YoY) and the FY2025 annual result came in at $8.7 billion, down 21.55% from the prior year.
- Total Non-Current Liabilities slipped to $8.6 billion in Q1 2026, from $8.7 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $11.4 billion in Q2 2024 to a low of $2.1 billion in Q4 2023.
- A 4-year average of $9.4 billion and a median of $10.8 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities surged 421.79% — and 2025, when it fell 23.99%.
- Tracing SOLV's Total Non-Current Liabilities over 4 years: stood at $2.1 billion in 2023, then surged by 421.79% to $11.1 billion in 2024, then decreased by 21.55% to $8.7 billion in 2025, then declined by 0.55% to $8.6 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $8.6 billion (Q1 2026), $8.7 billion (Q4 2025), and $8.6 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.64 Bn | 129.42 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.62 Bn | 51.76 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.79 Bn | 34.43 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.71 Bn | 32.25 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.27 Bn | 26.59 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 24.96 Bn | 24.53 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.45 Bn | 15.04 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.84 Bn | 14.70 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.54 Bn | 11.39 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Align Technology | 11.54 Bn | 10.44 Bn | 757.43 Mn | 2.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.96 Bn |
| Mar 31, 2026 | 8.65 Bn |
| Dec 31, 2025 | 8.70 Bn |
| Sep 30, 2025 | 8.55 Bn |
| Jun 30, 2025 | 11.06 Bn |
| Mar 31, 2025 | 10.99 Bn |
| Dec 31, 2024 | 11.09 Bn |
| Sep 30, 2024 | 11.25 Bn |
| Jun 30, 2024 | 11.41 Bn |
| Mar 31, 2024 | 10.69 Bn |
| Dec 31, 2023 | 2.13 Bn |